Banerjee D - Search Results

1

A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance.

Mishra PJ, Humeniuk R, Mishra PJ, Longo-Sorbello GS, Banerjee D, Bertino JR. Mishra PJ, et al. Among authors: banerjee d. Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13513-8. doi: 10.1073/pnas.0706217104. Epub 2007 Aug 8. Proc Natl Acad Sci U S A. 2007. PMID: 17686970 Free PMC article.

2

MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics.

Mishra PJ, Mishra PJ, Banerjee D, Bertino JR. Mishra PJ, et al. Among authors: banerjee d. Cell Cycle. 2008 Apr 1;7(7):853-8. doi: 10.4161/cc.7.7.5666. Epub 2008 Jan 28. Cell Cycle. 2008. PMID: 18414050 Review.

3

Species-specific differences in translational regulation of dihydrofolate reductase.

Hsieh YC, Skacel NE, Bansal N, Scotto KW, Banerjee D, Bertino JR, Abali EE. Hsieh YC, et al. Among authors: banerjee d. Mol Pharmacol. 2009 Oct;76(4):723-33. doi: 10.1124/mol.109.055772. Epub 2009 Jul 1. Mol Pharmacol. 2009. PMID: 19570950 Free PMC article.

4

MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism.

Mishra PJ, Song B, Mishra PJ, Wang Y, Humeniuk R, Banerjee D, Merlino G, Ju J, Bertino JR. Mishra PJ, et al. Among authors: banerjee d. PLoS One. 2009 Dec 24;4(12):e8445. doi: 10.1371/journal.pone.0008445. PLoS One. 2009. PMID: 20041160 Free PMC article.

5

Cells exposed to antifolates show increased cellular levels of proteins fused to dihydrofolate reductase: a method to modulate gene expression.

Mayer-Kuckuk P, Banerjee D, Malhotra S, Doubrovin M, Iwamoto M, Akhurst T, Balatoni J, Bornmann W, Finn R, Larson S, Fong Y, Gelovani Tjuvajev J, Blasberg R, Bertino JR. Mayer-Kuckuk P, et al. Among authors: banerjee d. Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3400-5. doi: 10.1073/pnas.062036899. Epub 2002 Mar 12. Proc Natl Acad Sci U S A. 2002. PMID: 11891321 Free PMC article.

6

Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene.

Budak-Alpdogan T, Alpdogan O, Banerjee D, Wang E, Moore MA, Bertino JR. Budak-Alpdogan T, et al. Among authors: banerjee d. Mol Ther. 2004 Sep;10(3):574-84. doi: 10.1016/j.ymthe.2004.06.115. Mol Ther. 2004. PMID: 15336657 Free article.

7

Hematopoietic stem cell gene therapy with drug resistance genes: an update.

Budak-Alpdogan T, Banerjee D, Bertino JR. Budak-Alpdogan T, et al. Among authors: banerjee d. Cancer Gene Ther. 2005 Nov;12(11):849-63. doi: 10.1038/sj.cgt.7700866. Cancer Gene Ther. 2005. PMID: 16037821 Review.

8

Epigenetic reversal of acquired resistance to 5-fluorouracil treatment.

Humeniuk R, Mishra PJ, Bertino JR, Banerjee D. Humeniuk R, et al. Among authors: banerjee d. Mol Cancer Ther. 2009 May;8(5):1045-54. doi: 10.1158/1535-7163.MCT-08-0717. Epub 2009 Apr 21. Mol Cancer Ther. 2009. PMID: 19383845

9

Decreased levels of UMP kinase as a mechanism of fluoropyrimidine resistance.

Humeniuk R, Menon LG, Mishra PJ, Gorlick R, Sowers R, Rode W, Pizzorno G, Cheng YC, Kemeny N, Bertino JR, Banerjee D. Humeniuk R, et al. Among authors: banerjee d. Mol Cancer Ther. 2009 May;8(5):1037-44. doi: 10.1158/1535-7163.MCT-08-0716. Epub 2009 Apr 21. Mol Cancer Ther. 2009. PMID: 19383847

10

Translational modulation of proteins expressed from bicistronic vectors.

Mishra PJ, Menon LG, Mishra PJ, Mayer-Kuckuk P, Bertino JR, Banerjee D. Mishra PJ, et al. Among authors: banerjee d. Mol Imaging. 2009 Dec;8(6):305-18. Mol Imaging. 2009. PMID: 20003889 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,994 results

Search Page

Filters